Neutralizing molecules to ANG2 can block tumor growth in vitro13, which subsequently led to the use of anti-ANG2 monoclonal antibodies in clinical trials for the treatment of solid tumors14, 15. The gene discussed is ANGPT2; the disease is neoplasm.